Why do we need a new hepatology journal?
Today, World Hepatitis Day, is a time for celebrating all forms of progress in combating this group of diseases. It’s also an opportunity to ask what more… Read more »
Jeffrey V. Lazarus
Prof Jeffrey V. Lazarus is on the faculty at the Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona and at CHIP, the Centre for Health and Infectious Disease Research and WHO Collaborating Centre on HIV and Viral Hepatitis at Rigshospitalet, the University of Copenhagen. He also serves as the Board Chair of AFEW International, a Board member of the EASL International Liver Foundation, a steering committee member of the HIV in Europe Initiative, the ACHIEVE Hepatitis Elimination coalition and of the European Commission’s joint action on HIV and hepatitis. He is a member of the BMC Editorial Advisory Group.
Latest posts by Jeffrey V. Lazarus (see all)
- The challenge of sustainable funding – Jurgita Poškevičiūtė on financing harm reduction in Lithuania - 7th March 2018
- Unlocking state money for harm reduction – Darko Antik on helping NGOs in Macedonia - 23rd February 2018
- Securing crucial funding for harm reduction in a challenging setting: Iva Jovović discusses LET, the quality-of-life improvement NGO in Croatia - 18th October 2017
The impact factor’s ill effects on health systems work: what can WE do?
Does the impact factor have undue influence? Prof Jeffrey V. Lazarus explores the negative effects of the impact factor on health systems research, both now and… Read more »
Hepatitis in Europe – the hidden epidemic
As the HepHIV 2014 Conference in Barcelona continues, guest blogger Professor Jeffrey Lazarus tells us about the challenges we face to combat hepatitis in… Read more »